Introduction
============

Acute aortic dissection (AAD) is a common and critical clinical disease with a high rate of mortality; however, its pathogenetic mechanism requires further investigation. Recent studies suggested that AAD arises from problems with vascular function. It is well established that vascular smooth muscle cells (VSMCs) are essential regulators of vascular function ([@b1-mmr-19-04-3105]). VSMCs are located in the middle vascular layer of healthy arteries ([@b2-mmr-19-04-3105]--[@b4-mmr-19-04-3105]), where they secrete vasoconstrictor proteins that help regulate blood vessel tension and blood flow ([@b5-mmr-19-04-3105]). VSMCs are the most important component of the vascular middle layer and may contribute to AAD. VSMCs are divided into two cell phenotypes: Contractile and synthetic ([@b6-mmr-19-04-3105],[@b7-mmr-19-04-3105]). Fusiform contractile VSMCs demonstrate difficulty in secreting extracellular matrix proteins, and exhibit poor proliferation and migration ([@b8-mmr-19-04-3105]). The proliferative and migration abilities of synthetic VSMCs are enhanced compared with the systolic VSMCs ([@b9-mmr-19-04-3105]--[@b11-mmr-19-04-3105]). Synthetic VSMCs secrete a variety of extracellular matrix components, including collagen, elastin and proteoglycans ([@b12-mmr-19-04-3105],[@b13-mmr-19-04-3105]). Upon atherosclerosis and arterial restenosis, VSMCs undergo a transformation from the contractile to the synthetic phenotype ([@b14-mmr-19-04-3105]). This transformation promotes the migration of SMCs into the intima, enhances proliferation and promotes the secretion of extracellular proteins ([@b15-mmr-19-04-3105]). These phenotypic transformations may underlie the basis of regulating the composition and stability of blood vessels, which may eventually lead to the formation of vascular lesions ([@b16-mmr-19-04-3105]). Recent studies revealed that extracellular factors and downstream signaling pathways participate in transformation of VSMCs ([@b17-mmr-19-04-3105],[@b18-mmr-19-04-3105]), such as autophagy.

It was demonstrated that Rab7 participates in the regulation of VSMC proliferation and migration ([@b2-mmr-19-04-3105]). Autophagy, induced by platelet-derived growth factor, serves an important role in the process of transforming the phenotype of VSMCs from a contractile to a synthetic form by preventing oxidative stress-induced cell death ([@b19-mmr-19-04-3105]). Rab proteins are Ras-related small GTPases, which regulate exo- and endocytic membrane trafficking by vesicle docking and fusion ([@b20-mmr-19-04-3105]). As an important member of the Rab GTPase superfamily, Rab7 promotes lysosomal biosynthesis and maintains lysosomal function ([@b21-mmr-19-04-3105],[@b22-mmr-19-04-3105]). Furthermore, Rab7 serves a pivotal role in the fusion of vesicles and lysosomes, and exhibit an important effect on autophagosome maturation ([@b23-mmr-19-04-3105]). Abnormal expression or alterations in the activity of Rab7 may be associated with cardiovascular diseases, lipid storage disorders and neurodegenerative diseases ([@b24-mmr-19-04-3105]--[@b27-mmr-19-04-3105]). Therefore, the present study hypothesized that phenotypic transformation regulated by Rab7-mediated autophagy may be associated with VSMC proliferation and invasion.

In the present study, AD VSMCs were treated with small interfering (si)RNA or Rab7 overexpression plasmid to assess phenotypic transformations and cellular behavior, including proliferation, invasion, cell cycle and autophagy. The present study aimed to identify the effects of Rab7 on autophagy in VSMCs and determine whether -Rab7-regulated autophagy results in the alteration of VSMC phenotype and cell behavior.

Materials and methods
=====================

### Tissue sampling

A total of 51 AAD tissues were obtained from patients with type A AD, who underwent aortic replacement operations at The First Affiliated Hospital of Nanjing Medical University (Nanjing, China) between October 2015 and October 2017 (Ethics no. 2016-SR-144). The main clinicopathological characteristics of the patients are shown in [Table I](#tI-mmr-19-04-3105){ref-type="table"}. All experimental protocols were approved by the Ethics Committee of The First Affiliated Hospital of Nanjing Medical University and all patients provided written informed consent. Patients with hereditary connective tissue defects, including Marfan syndrome or traumatic aneurysms, were excluded. The control group comprised 14 non-aortic dissection (NAD) aortic specimens collected from organ donors, containing residual tissues from organ pruning, such as the aortic tissue trimmed during heart transplantations. No significant differences between the groups were observed with respect to the clinical characteristics, including patient age, sex, smoking status, hypertension or diabetes.

### Immunohistochemistry

The fresh tissues were fixed in 4% paraformaldehyde at room temperature for 48 h dehydrated in a graded ethanol series and embedded in paraffin. Then, 5 µm thick sections were dewaxed twice in xylene for 10 min and rehydrated in ethanol (75% ethanol 2 h, 95% ethanol 1.5 h, 95% ethanol 1.0 h, absolute ethyl alcohol 1.5 h and absolute ethyl alcohol 1.0 h) at room temperature. The sections were washed with PBS (pH 7.4) 3 times for 3 min. Then, the slides were boiled in 10 mM/l citrate buffer (pH 6.0) in an autoclave for 3 min for antigen retrieval. Following slow cooling, the sections were blocked by immersion in 3% methanolic peroxide for 15 min at room temperature and incubated with the following primary antibodies: Antibodies against Rab7 (ab50533; 1:500; Abcam, Cambridge, UK) overnight at 4°C, followed by horseradish peroxidase (HRP)-conjugated secondary antibodies for 2 h at room temperature (31430; 1:5,000; Thermo Fisher Scientific, Inc., Waltham, MA, USA). After washing with water, the slides were counterstained with hematoxylin for 2 min at room temperature, dehydrated and mounted in resin mountant.

### Cell culture

Primary human aortic VSMCs (HASMCs) were isolated from the collected tissues using the tissue adhesion method ([@b28-mmr-19-04-3105]); subsequent experiments were performed with 2nd-4th generation cells. Cells were cultured in smooth muscle cell medium (Sciencell Research Laboratories, Inc., San Diego, CA, USA) containing 10% fetal bovine serum (Sciencell Research Laboratories, Inc.). Cells were grown in cell culture flasks (Corning, Inc., Corning, NY, USA) in a humidified environment in 37°C with 5% CO~2~.

### Cell transfection

siRab7, and Rab7 overexpression and control vectors were obtained from Shanghai GeneChem Co., Inc. (Shanghai, China). Sequences were: siRab7\#1: 5′GUCUAGUUCCCUUCUGUGU(dTdT)3′; siRab7\#2: 5′ACACAGAAGGGAACUAGAC(dTdT)3′. A total of 20 nM of siRNAs were transfected into the cells using RNAiMAX (Invitrogen; Thermo Fisher Scientific, Inc.) according to the manufacturer\'s protocol. All siRNAs were purchased from Shanghai GeneChem Co., Inc. (Shanghai, China). Transfection efficiency was determined using western blot analysis.

### 5′Ethynyl-2′-deoxyuridine (EdU) assay

Briefly, the cells were plated into 12-well plates at a density of 8×10^3^ cells/well with 500 µl culture medium. Cells were fixed at room temperature for 20 min using 4% paraformaldehyde (PFA), then permeabilized with 0.2% Triton X-100 at room temperature for 20 min and blocked with 10% goat serum (Abcam) in TBS containing 0.05% Tween-20 (TBST) for 1 h at room temperature. The EdU assay was performed using the Click-iT Plus EdU Alexa Fluor^®^ 488 Imaging kit (Invitrogen; Thermo Fisher Scientific, Inc.) according to the manufacturer\'s protocols to determine cell proliferation. Nuclei were counterstained with DAPI at room temperature for 10 min. Under a confocal microscope (Zeiss AG, Oberkochen, Germany), 15 fields/sample (magnification, ×200) were observed and the number of EdU-positive nuclei was determined.

### Transwell invasion assay

Transwell invasion assays were performed using Transwell chambers (pores, 8 mm; Corning, Inc.). Serum-free medium containing 1×10^4^ cells was added to the upper chamber pre-coated with Matrigel (BD Biosciences, San Jose, CA, USA). Following 24 h incubation in 37°C with 5% CO~2~ cells that migrated to the lower surface of the membrane were fixed with absolute ethanol and stained with 0.1% crystal violet at room temperature for 10 min. Cells in the upper chamber were wiped from the Matrigel with a cotton swab. Then, 3 visual fields were randomly selected to screen the cells located on the lower surface of the membrane under an inverted microscope. After calculating the number of cells in every field, the average was counted and analyzed.

### Cell cycle analysis

Flow cytometry was performed to detect the cell cycle. Cells were cultured to 80--90% confluence in 6-well plates. Cells were transfected for 48 h, digested with 0.25% trypsin at room temperature for 10 min, collected with pre-chilled 70% ethanol at 4°C and maintained at 4°C for overnight fixation. Cells were collected by centrifugation at 150 × g for 10 min at 4°C; the upper layer was discarded and ethanol was washed away with PBS. The cells were then stained with PI DNA staining solution (Hangzhou Lianke Biology Technology, Co., Ltd., Hangzhou, China) at room temperature for 30 min. A Beckman Gallios (AU39633; Beckman Coulter, Inc., Brea, CA, USA) and Wincycle version 3.0 (Beckman Coulter, Inc.) were used for cell cycle analysis.

### Detection of autophagy

Immunofluorescence and western blot analysis were used to determine autophagy. For immunofluorescence assays, HASMCs were cultured to 80--90% confluence in 6-well plates.

The cells were fixed in 4% PFA at room temperature for 20 min, followed by 0.2% Triton X-100 for 20 min and permeabilization with 10% goat serum in TBST for 1 h at room temperature. Cells were incubated with rabbit polyclonal anti-microtubule-associated protein light chain 3 (LC3) antibody (ab48394; 1:100; Abcam, Cambridge, UK) at 4°C overnight. Cells were then incubated with Alexa Fluor 488-labeled secondary antibody (5 µg/ml; A-11034; Thermo Fisher Scientific, Inc.) for 1 h at room temperature and imaged using an inverted fluorescence microscope. The expression of Beclin-1 (ab62557; 1:1,000; Abcam), LC3 (ab48394; 1:1,000; Abcam) and P62 (ab56416; 1:1,000; Abcam) were detected by western blotting (described below). Following the administration of 3-methyladenine (3-MA; 5 mM), a pharmacological inhibitor of autophagy, to Rab7-overexpressing cells at 37°C with 5% CO~2~ for 48 h, α-SMA (ab5694; 1:1,000; Abcam) and Osteopintin (ab8448; 1:1,000; Abcam) were detected by western blotting (as described below).

### Protein extraction and western blotting

Following washes with PBS for 3 times, proteins were extracted from the cells using radioimmunoprecipitation assay lysis buffer containing phenylmethylsulfonyl fluoride and protease inhibitors (R0010; Beijing Solarbio Science & Technology Co., Ltd., Beijing, China). A Bicinchoninic Acid Protein Assay kit (Beyotime Institute of Biotechnology, Shanghai, China) was used to quantify the total protein. SDS-PAGE (12%) was used to separate the proteins (30 µg/lane) prior to transfer to polyvinylidene difluoride membranes (0.45 µm; EMD Millipore, Billerica, MA, USA). Subsequently, membranes were blocked with TBST and 5% fat-free dry milk for 2 h at room temperature. Membranes were incubated with primary antibodies (Beclin-1; ab62557; 1:1,000, LC3; ab48394; 1:1,000 and P62; 1:1,000; ab56416; all from Abcam) in TBST containing 1% bovine serum albumin (ScienCell Research Laboratories, Inc., San Diego, CA, USA) overnight at 4°C, followed by incubation with horseradish peroxidase-conjugated secondary antibody at an appropriate dilution with TBST (1:3,000; ab97080 and ab97040; Abcam, UK) at room temperature for 2 h. Membranes were washed three times for 10 min washes with TBST. A ChemiDoc XRS (Bio-Rad Laboratories, Inc., Hercules, CA, USA) and Supersignal West Femto Trial kit (Thermo Fisher Scientific, Inc.) were used to visualize the bands. Relative protein levels were determined using Image J version 1.45s software (National Institutes of Health, Bethesda, MD, USA).

### Statistical analysis

All data are presented as the mean ± standard deviation. SPSS version 17.0 software (SPSS, Inc., Chicago, IL, USA) was used to perform statistical analysis. A Student\'s t-test was applied to analyze the expression of Rab7 in AD tissues compared with paired NAD tissues. The association between the clinicopathological characteristics of patients and Rab7 expression was determined using Fisher\'s exact test, analysis of variance (ANOVA) and a Student\'s t-test. Data were analyzed via one-way ANOVA for 3-group comparisons and two tail student\'s t-tests for 2-group comparisons. P\<0.05 was considered to indicate a statistically significant difference.

Results
=======

### Rab7 is overexpressed in AD tissue and the abundance of synthetic HASMCs is increased in AD

Rab7 protein expression levels in 14 NAD and 51 AD specimens were determined by western blotting, and were normalized to GAPDH. The results revealed that the expression levels of Rab7 were significantly increased in AD specimens compared with the NAD samples (P\<0.001; [Fig. 1A](#f1-mmr-19-04-3105){ref-type="fig"}). [Table I](#tI-mmr-19-04-3105){ref-type="table"} demonstrated the association between Rab7 protein expression and the clinicopathological characteristics in patients with AD. In addition, the expression of Rab7, α-SMA and osteopontin was determined by western blotting. It was observed that Rab7 and osteopontin expression was notably increased in the AD specimens, while α-SMA expression was decreased compared with the NAD specimens ([Fig. 1B](#f1-mmr-19-04-3105){ref-type="fig"}). Using immunohistochemistry, it was observed that the AD specimens had significantly higher Rab7 expression compared with in NAD specimens ([Fig. 1C and D](#f1-mmr-19-04-3105){ref-type="fig"}). These results indicated that the abundance of contractile HASMCs was decreased while synthetic HASMCs were increased in AD ([@b29-mmr-19-04-3105],[@b30-mmr-19-04-3105]).

### Rab7 regulates HASMC proliferation, invasion and cell cycle

As presented in [Fig. 1B](#f1-mmr-19-04-3105){ref-type="fig"}, Rab7 expression in Case 4 of the AD group was markedly increased compared with the NAD group and Rab7 expression in Case 8 was markedly decreased compared with other AD cases. Thus, Rab7 knockdown was performed in Case 4 HASMCs and Rab7 overexpression was conducted in Case 8 HASMCs to investigate the effects of Rab7 on proliferation, invasion and the cell cycle. The transfection efficiency was demonstrated for the Case 4 knockdown and Case 8 overexpression using western blot analysis ([Fig. 2A](#f2-mmr-19-04-3105){ref-type="fig"}).

EdU assays were performed to evaluate the effects of Rab7 on proliferation. HASMC proliferation was significantly decreased in Rab7 knockdown compared with the transfected siCtrl Case 4 control ([Fig. 2B](#f2-mmr-19-04-3105){ref-type="fig"}) and Rab7 overexpression significantly promoted HASMC proliferation compared with the transfected siCtrl Case 8 control ([Fig. 2B](#f2-mmr-19-04-3105){ref-type="fig"}). Rab7 knockdown in HASMCs using siRab7\#1 and siRab7\#2 was observed to significantly decrease the number of invaded cells compared with the Case 4 control; this was significantly reversed in the Case 8 overexpression group compared with the control ([Fig. 2C](#f2-mmr-19-04-3105){ref-type="fig"}). The results indicated that Rab7 significantly affected the proliferation and invasion of HASMCs.

Analysis of the cell cycle distribution revealed that Rab7 was able to regulate the HASMC cycle. Compared with the Case 4 control, significantly fewer cells were observed in the G1 phase, and a significantly higher proportion of cells in the G2 and S phase were detected following knockdown of Rab7 with siRab7\#1 or siRab7\#2 ([Fig. 2D and F](#f2-mmr-19-04-3105){ref-type="fig"}). Cell cycle analysis of HASMCs overexpressing Rab7 exhibited opposing results, with a significant increase in G1 cell number, and notable decreases in the G2 and S phase cell number compared with the control group ([Fig. 2E and G](#f2-mmr-19-04-3105){ref-type="fig"}). The results suggested that Rab7 upregulation may induce cell cycle arrest in the G1 phase.

### Rab7 regulates autophagy

Immunofluorescence assays were performed to determine the effects of Rab7 on autophagy. Based on the literature, Beclin1, LC3-II and P62 were selected as markers in the evaluation of autophagy. Immunofluorescence assays demonstrated that HASMC autophagy was significantly decreased following Rab7 knockdown in Case 4 compared with the control cells ([Fig. 3A](#f3-mmr-19-04-3105){ref-type="fig"}); overexpression promoted HASMC autophagy compared with Case 8 control cells ([Fig. 3A](#f3-mmr-19-04-3105){ref-type="fig"}). Rab7 knockdown in Case 4 notably decreased Beclin1 and LC3-II, and increased P62 expression compared with the control. These effects were reversed in Rab7 overexpressing cells compared with the Case 8 control ([Fig. 3B](#f3-mmr-19-04-3105){ref-type="fig"}). This suggested that Rab7 inducted HASMC autophagy.

### Rab7 regulates the phenotypic transformations of HASMCs by inducing autophagy

The effects of Rab7 on phenotypic transformations were determined by detecting α-SMA and osteopontin expression. α-SMA is mainly expressed in contractile HASMCs, while osteopontin is mainly expressed in synthetic HASMCs ([@b31-mmr-19-04-3105],[@b32-mmr-19-04-3105]). It was demonstrated that α-SMA expression was significantly increased in Rab7 knockdown cells of Case 4 compared with the control cells ([Fig. 4A](#f4-mmr-19-04-3105){ref-type="fig"}) and Rab7 overexpression in Case 8 cells inhibited α-SMA expression compared with the control cells ([Fig. 4B](#f4-mmr-19-04-3105){ref-type="fig"}). Furthermore, osteopontin expression was decreased in Rab7 knockdown cells and increased in Rab7 overexpression cells compared with the Case 4 and Case 8 controls, respectively ([Fig. 4A and B](#f4-mmr-19-04-3105){ref-type="fig"}). The results indicated that Rab7 significantly promoted HASMC phenotypic transformations from a contractile to a synthetic phenotype.

To further investigate whether the phenotypic transformation of SMCs is regulated by Rab7-mediated autophagy, a pharmacological inhibitor of autophagy, 3-MA, was administered to Rab7-overexpressing cells to suppress autophagy. When autophagy was inhibited by 3-MA, it was observed that α-SMA, osteopontin and LC3 expression was markedly altered compared with the control ([Fig. 4B](#f4-mmr-19-04-3105){ref-type="fig"}). In conclusion, Rab7 was observed to induce autophagy, which may be associated with the phenotypic transformation of HASMCs.

### Rab7 activates the Ras/Raf/mitogen-activated protein kinase (MAPK) kinase (MEK)/extracellular signal-regulated kinase (ERK) signaling pathway in HASMCs

The Ras/Raf/MEK/ERK signaling pathway serves an important role in autophagy ([@b33-mmr-19-04-3105],[@b34-mmr-19-04-3105]). The expression levels of various molecules of the Ras/Raf/MEK/ERK signaling pathway were analyzed by western blotting. Rab7 knockdown resulted in decreased expression of K-Ras, phosphorylated (p)-BRAF, p-MEK and p-ERK in Case 4 cells compared with the transformed siCtrl control ([Fig. 5A](#f5-mmr-19-04-3105){ref-type="fig"}). In Rab7-overexpressing cells, the expression of K-Ras, p-BRAF, p-MEK and p-ERK was increased in Case 8 cells compared with the control ([Fig. 5B](#f5-mmr-19-04-3105){ref-type="fig"}). As the Ras/Raf/MEK/ERK signaling pathway is associated with autophagy ([@b35-mmr-19-04-3105]), the results of the present study suggested that Rab7 induced autophagy by activating the Ras/Raf/MEK/ERK signaling pathway in HASMCs.

Discussion
==========

Analyses into the pathogenesis of AD have become more widespread and various factors that contribute to the development of AD have been identified, such as hereditary diseases, including Marfan syndrome, hypertension, atherosclerosis and autoimmune diseases ([@b36-mmr-19-04-3105]--[@b38-mmr-19-04-3105]); however, the molecular mechanism underlying the development and progression of AD remains unknown. It is well established that normal aortic media comprises numerous regularly arranged VSMCs and extracellular matrix ([@b39-mmr-19-04-3105]). As SMCs are associated with the structure and function of the aorta, there is the potential for serving important roles in AD development ([@b40-mmr-19-04-3105]--[@b42-mmr-19-04-3105]). In healthy individuals, contractile VSMCs serve a crucial role in maintaining vascular wall structure and function ([@b43-mmr-19-04-3105]). In patients with AD, a significant increase in the number and ratio of synthetic VSMCs was observed, which resulted in decreased aortic elasticity and rupture of the vessel wall ([@b44-mmr-19-04-3105],[@b45-mmr-19-04-3105]). These studies suggested that the phenotypic conversion of VSMCs may be the key factor underlying the occurrence and development of AD.

Previous studies have reported that numerous factors, including vasoconstrictor agonists and extracellular matrices regulate the phenotypic conversion of VSMCs ([@b46-mmr-19-04-3105],[@b47-mmr-19-04-3105]). While contractile VSMCs express α-SMA extensively, synthetic VSMCs exhibit high expression of osteopontin ([@b31-mmr-19-04-3105]). The present study reported that Rab7 downregulation resulted in increased α-SMA and osteopontin expression. These results suggested that Rab7 may promote the phenotypic conversion of contractile to synthetic VSMCs; however, the specific mechanism remains unclear. Rab7, a member of the Rab GTPase superfamily, serves an unique role in the regulation of autophagy ([@b48-mmr-19-04-3105]). Several studies have revealed that autophagy promotes the phenotypic conversion of contractile to synthetic VSMCs ([@b19-mmr-19-04-3105],[@b49-mmr-19-04-3105],[@b50-mmr-19-04-3105]). Therefore, the present study proposed that autophagy may be affected by the phenotypic transformations VSMCs mediated by Rab7. To further verify this hypothesis, the autophagy inhibitor 3-MA was applied to cells to investigate whether Rab7 promotes the phenotypic transformations of VSMCs. It was observed that the effects of Rab7 on phenotypic transformations were reversed following autophagy inhibition. In conclusion, autophagy may be a key component in Rab7-inducing phenotypic transformations. The effects of Rab7 on phenotypic transformations were revealed via the suppression of autophagy in Rab7 knockdown cells; the phenotypic transformations were associated with autophagy in Rab7 overexpressing cells.

Furthermore, as autophagy is regulated by the Ras/Raf/MEK/ERK signaling pathway ([@b33-mmr-19-04-3105],[@b35-mmr-19-04-3105]), it was proposed that Rab7 may induce autophagy-mediated phenotypic transformations via the Ras/Raf/MEK/ERK signaling pathway. It was observed that Rab7 knockdown or overexpression regulated the expression of Ras/Raf/MEK/ERK signaling pathway-associated proteins. Future experiments are required investigate the effects of the Ras/Raf/MEK/ERK signaling pathway on Rab7-mediated VSMC phenotypic transformations.

The present study revealed that Rab7 promoted VSMC proliferation and invasion in AD. This phenomenon may be associated with autophagy and phenotypic transformations. Autophagy has been considered to be the basic catabolic mechanism that is essential for cell survival, differentiation, development and the cellular response to stress via the regulating the actions of numerous lysosomes ([@b51-mmr-19-04-3105]--[@b53-mmr-19-04-3105]). In aortic endothelial cells, autophagy promotes tube formation and endothelial cell migration by inducing angiogenesis ([@b54-mmr-19-04-3105]). Additionally, in lung cancer cells, autophagy facilitates proliferation, migration and invasion ([@b55-mmr-19-04-3105]). VSMCs of the synthetic phenotype have enhanced proliferative and migration abilities compared with the contractile phenotype ([@b56-mmr-19-04-3105],[@b57-mmr-19-04-3105]). Compared with healthy controls, the present study positively correlated VSMC proliferation and invasion with autophagy and phenotypic transformations in AD. In the present study, autophagy and phenotypic transformations were reported to be regulated by Rab7, which in turn was supported by Rab7 promoting VSMC proliferation and invasion in AD; however, the exact mechanism of action remains unclear and requires further investigation.

There are certain limitations to the present study. Synthetic VSMCs synthesize and secrete extracellular matrices ([@b58-mmr-19-04-3105]); however, the expression of extracellular matrix proteins, including collagen and elastin were not detected in the present study. Therefore, the role of Rab7 and the Ras/Raf/MEK/ERK signaling pathway in extracellular matrix-associated protein secretion remains unknown. Additionally, as VSMC phenotypic conversion is associated with AD development and various cardiovascular events including coronary heart disease and vascular complications in diabetes ([@b59-mmr-19-04-3105]), further investigation into phenotypic transition is essential for the prevention and treatment of particular cardiovascular diseases.

In summary, Rab7 promoted the proliferation and invasion of VSMCs in AD, which may be mediated by the regulation of autophagy and phenotypic transformation. Additionally, Rab7 expression was associated with the Ras/Raf/MEK/ERK signaling pathway. These results indicate the important role of Rab7 in the etiology of AD and suggested that Rab7 may be considered as a novel therapeutic target for the treatment of AD; however, further experiments are required to determine the underlying mechanism of Rab7 in the regulation of autophagy and phenotypic transformation.
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![Rab7 expression is increased in AD tissues. (A) Western blotting revealed the upregulation of Rab7 protein in 51 AD tissues compared with 14 NAD tissues. \*\*\*P\<0.001 vs. CON. (B) Rab7 and osteopontin protein expression levels increased in 10 AD tissues compared with 3 NAD tissues. α-SMA expression levels were decreased in AD tissues compared with the control. (C and D) Representative immunohistochemical staining of Rab7 was stronger in AD samples compared with in NAD tissues. Scale bar, 100 µm. \*\*P\<0.01 vs. CON. α-SMA, α-smooth muscle actin; AD, aortic dissection; CON, control; NAD, non-aortic dissection.](MMR-19-04-3105-g00){#f1-mmr-19-04-3105}

![HASMC proliferation and invasion is regulated by Rab7 *in vitro*. (A) Transfection efficiency was demonstrated for the Case 4 knockdown and Case 8 overexpression using western blot analysis. (B) Rab7 knockdown inhibited Case 4 HASMC proliferation and overexpression promoted Case 8 HASMC proliferation as determined by an EdU assay. \*\*P\<0.01 and \*\*\*P\<0.001 vs. CON. Scale bar=200 µm. (C) *In vitro*, HASMC invasion decreased in the Rab7 knockdown group and increased in the Rab7 overexpression group compared with the respective controls. \*\*P\<0.01 vs. CON. Scale bar=200 µm. (D and F) HASMC cell cycle was regulated by Rab7 *in vitro*. Rab7 knockdown induced G1 arrest in Case 4 HASMCs compared with the control (\*\*P\<0.01 vs. CON); the proportion of cells in the S phase was increased (\*\*P\<0.01 vs. CON) and the proportion of cells in G2 phase markedly changed (P\>0.05 vs. CON). (E and G) Rab7 overexpression in Case 8 HASMCs increased the number of cells in G1 phase (\*\*P\<0.01 vs. CON); the number of cells in S phase decreased (\*\*\*P\<0.001 vs. CON) and that of G2 cells markedly changed (P\>0.05 vs. CON). CON, control; EdU, 5′ethynyl-2′-deoxyuridine; HASMCs, human aortic smooth muscle cells; siCtrl, small interfering RNA control; siRab7, siRNA Rab7.](MMR-19-04-3105-g01){#f2-mmr-19-04-3105}

![HASMC autophagy is regulated by Rab7 *in vitro*. (A) Immunofluorescence assays revealed that LC3 expression was decreased in Rab7 knockdown cells compared with the control (Case 4; \*\*\*P\<0.001 vs. Ctrl) and upregulated in Rab7 overexpressing HASMCs compared with the control (Case 8; \*\*P\<0.01 vs. Ctrl). Scale bar=200 µm. (B) Rab7, Beclin1 and LC3-II protein levels decreased in siRab\#1 and siRab\#2 groups, and P62 protein levels were increased compared with the siCtrl group (Case 4) as determined by western blotting. Overexpression of Rab7 notably increased the expression of Rab7, Beclin1 and LC3-II, and downregulated that of P62 levels compared with the control (Case 8). Scale bar=200 µm. Ctrl, control; HASMCs, human aortic smooth muscle cells; LC3, microtubule-associated protein light chain 3; siCtrl, small interfering RNA control; siRab7, siRNA Rab7.](MMR-19-04-3105-g02){#f3-mmr-19-04-3105}

![HASMC phenotypic transformations are regulated by Rab7 *in vitro*. (A) Western blotting revealed Rab7 downregulation in Case 4 HASMCs. Following Rab7 knockdown, α-SMA expression was notably increased and osteopontin levels were decreased compared with the control. \*\*\*P\<0.001 vs. CON. (B) Overexpression of Rab7 promoted phenotypic transformation in Case 8 HASMC as indicted by alterations in the expression of α-SMA and osteopontin. 3-MA was used to inhibit autophagy; the expression of α-SMA and osteopontin was markedly altered in Rab7-overexpressing cells (Case 8). \*\*\*P\<0.001, \*P\<0.05 vs. CON. 3-MA, 3-methyladenine; Ctrl, control; HASMC, human aortic smooth muscle cells; LC3, microtubule-associated protein light chain 3; siCtrl, small interfering RNA control; siRab7, siRNA Rab7.](MMR-19-04-3105-g03){#f4-mmr-19-04-3105}

![Rab7 promotes the Ras/Raf/MEK/ERK signaling pathway. Expression of proteins associated with the Ras/Raf/MEK/ERK signaling pathway in Rab7 knockdown (A; Case 4) and overexpression (B; Case 8) in human aortic smooth muscle cells were analyzed by western blotting. MAPK, mitogen-activated protein kinase; MEK, MAPK kinase; p, phosphorylated; siRab7, small interfering RNA Rab7.](MMR-19-04-3105-g04){#f5-mmr-19-04-3105}

###### 

Association between Rab7 protein expression and clinicopathological characteristics in patients with AD.

  Group                      Sex (female/male)                                   Age (years)   Blood glucose (mmol/l)   Systolic pressure (mmHg)                                      Diastolic pressure (mmHg)
  -------------------------- --------------------------------------------------- ------------- ------------------------ ------------------------------------------------------------- ------------------------------------------------------------
  AD                         7/44                                                47.82±6.77    4.91±0.48                155.12±16.20                                                  84.67±11.57
  NAD                        2/12                                                45.50±5.56    4.75±0.56                125.71±7.53^[b](#tfn2-mmr-19-04-3105){ref-type="table-fn"}^   76.29±5.64^[c](#tfn3-mmr-19-04-3105){ref-type="table-fn"}^
  Relative Rab7 expression   /^[a](#tfn1-mmr-19-04-3105){ref-type="table-fn"}^   /             /                        0.256                                                         0.231

Not applicable.

P=0.000

P=0.011. AD, aortic dissection; NAD, non-aortic dissection.

[^1]: Contributed equally
